Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3Paraproteinemias 2Immunoglobulin Light-chain Amyloidosis 2Breast Neoplasms 2Stomach Neoplasms 1Recurrence 1Postoperative Complications 1Papillomavirus Infections 1Myelodysplastic Syndromes 1Intermittent Fasting 1Colorectal Neoplasms 1Advanced Hormone Receptor-Positive Breast Carcinoma 1

Interventions

Specimen Handling 7Radiotherapy, Intensity-Modulated 5Human Papillomavirus Recombinant Vaccine nonavalent 5Human Papillomavirus DNA Tests 5Colposcopy 5Cisplatin 5Patient Navigation 3Methods 3Early Intervention, Educational 3Carboplatin 3human papillomavirus vaccine, L1 type 16, 18 2epigallocatechin gallate 2artesunic acid 2artemisinin 2Standard of Care 2Practice Guidelines as Topic 2Papillomavirus Vaccines 2Mass Screening 2Educational Status 2Docetaxel 2Cytological Techniques 2Blood Specimen Collection 2toripalimab 1fludarabine phosphate 1fludarabine 1artenimol 1aldesleukin 1adacel 1Watchful Waiting 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × Clinical Protocols × 1 year × Clear all
NCT04206813 2026-04-29

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Boston Medical Center

Phase 4 Active not recruiting
352 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡